IL87747A - Suppositories containing a calcitonin and taurocholic acid or a pharmaceutically acceptable salt thereof as resorption enhancer - Google Patents

Suppositories containing a calcitonin and taurocholic acid or a pharmaceutically acceptable salt thereof as resorption enhancer

Info

Publication number
IL87747A
IL87747A IL87747A IL8774788A IL87747A IL 87747 A IL87747 A IL 87747A IL 87747 A IL87747 A IL 87747A IL 8774788 A IL8774788 A IL 8774788A IL 87747 A IL87747 A IL 87747A
Authority
IL
Israel
Prior art keywords
calcitonin
pharmaceutically acceptable
acceptable salt
taurocholic acid
suppositories containing
Prior art date
Application number
IL87747A
Other languages
English (en)
Other versions
IL87747A0 (en
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878721700A external-priority patent/GB8721700D0/en
Priority claimed from GB888801991A external-priority patent/GB8801991D0/en
Priority claimed from GB888805068A external-priority patent/GB8805068D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IL87747A0 publication Critical patent/IL87747A0/xx
Publication of IL87747A publication Critical patent/IL87747A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Epoxy Compounds (AREA)
IL87747A 1987-09-15 1988-09-14 Suppositories containing a calcitonin and taurocholic acid or a pharmaceutically acceptable salt thereof as resorption enhancer IL87747A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB878721700A GB8721700D0 (en) 1987-09-15 1987-09-15 Organic compounds
GB888801991A GB8801991D0 (en) 1988-01-29 1988-01-29 Improvements in/relating to organic compounds
GB888805068A GB8805068D0 (en) 1988-03-03 1988-03-03 Improvements in/relating to organic compounds

Publications (2)

Publication Number Publication Date
IL87747A0 IL87747A0 (en) 1989-02-28
IL87747A true IL87747A (en) 1992-05-25

Family

ID=27263605

Family Applications (1)

Application Number Title Priority Date Filing Date
IL87747A IL87747A (en) 1987-09-15 1988-09-14 Suppositories containing a calcitonin and taurocholic acid or a pharmaceutically acceptable salt thereof as resorption enhancer

Country Status (26)

Country Link
US (1) US5149537A (es)
JP (1) JPH01228919A (es)
KR (1) KR970003052B1 (es)
AT (1) AT396424B (es)
AU (1) AU614769B2 (es)
BE (1) BE1001937A3 (es)
CA (1) CA1330417C (es)
CH (1) CH677320A5 (es)
CY (1) CY1763A (es)
DE (1) DE3830245A1 (es)
DK (1) DK509888A (es)
ES (1) ES2012119A6 (es)
FI (1) FI87889C (es)
FR (1) FR2620331B1 (es)
GB (1) GB2209670B (es)
HK (1) HK19394A (es)
HU (1) HU203204B (es)
IL (1) IL87747A (es)
LU (1) LU87334A1 (es)
MY (1) MY103611A (es)
NL (1) NL8802274A (es)
NO (1) NO175518C (es)
NZ (1) NZ226162A (es)
PH (1) PH24766A (es)
PT (1) PT88491B (es)
SE (1) SE8803222L (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0520983A4 (en) * 1990-03-15 1993-04-28 Rhone-Poulenc Rorer International (Holdings) Inc. Calcitonin suppository formulations
GB9013448D0 (en) * 1990-06-15 1990-08-08 Sandoz Ltd Pharmaceutical resorption-improved somatostatin compositions,their preparation and use
DE4222647A1 (de) * 1991-07-15 1993-01-21 Sandoz Ag Peptid-zubereitungen
US5262172A (en) * 1992-06-19 1993-11-16 Digestive Care Inc. Compositions of gastric acid-resistant microspheres containing buffered bile acids
JPH0776527A (ja) * 1993-06-28 1995-03-20 Hayashibara Biochem Lab Inc 半固形製剤とその製造方法
US7135191B2 (en) * 1997-09-04 2006-11-14 Zsolt Istvan Hertelendy Urogenital or anorectal transmucosal vaccine delivery system
US7772220B2 (en) * 2004-10-15 2010-08-10 Seo Hong Yoo Methods and compositions for reducing toxicity of a pharmaceutical compound
EP1113785B1 (en) 1998-07-24 2005-04-13 Seo Hong Yoo Clear aqueous solutions of bile acids
US7303768B2 (en) * 1998-07-24 2007-12-04 Seo Hong Yoo Preparation of aqueous clear solution dosage forms with bile acids
US20050158408A1 (en) * 1998-07-24 2005-07-21 Yoo Seo H. Dried forms of aqueous solubilized bile acid dosage formulation: preparation and uses thereof
KR100848344B1 (ko) * 2000-02-04 2008-07-25 유서홍 담즙산 함유 청정 수용액 제형의 제조
US7145125B2 (en) 2003-06-23 2006-12-05 Advanced Optical Technologies, Llc Integrating chamber cone light using LED sources
PT1651249E (pt) 2003-07-23 2012-12-21 Novartis Ag Uso de calcitonina em osteoartrite
BRPI0514725A (pt) * 2004-08-30 2008-06-24 Seo Hong Yoo efeito neuroprotetor de udca solubilizado no modelo isquêmico focal
EP1809330B1 (en) * 2004-10-15 2011-04-27 Seo Hong Yoo Compositions for reducing toxicity of cisplatin, carboplatin, and oxaliplatin
EP2255812A1 (en) * 2004-11-01 2010-12-01 Seo Hong Yoo Methods and compositions for reducing neurodegeneration in amyotrophic lateral sclerosis
US8143314B1 (en) 2007-09-13 2012-03-27 Robert Carl Stover Methods and formulations for treating ineffective or decreased esophageal motility
KR102287352B1 (ko) * 2015-06-30 2021-08-06 (주)아모레퍼시픽 화장료 조성물

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH211204A (de) * 1938-12-13 1940-08-31 Chem Ind Basel Verfahren zur Herstellung einer Suppositoriengrundmasse.
US4164573A (en) * 1975-06-13 1979-08-14 Galinsky Alvin M Composition and method for making a suppository for introducing a hypoglycemic agent into a mammal
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
ATE8584T1 (de) * 1980-01-16 1984-08-15 Hans Georg Prof. Dr. Weder Verfahren und dialysiereinrichtung zur herstellung von bilayer-vesikeln und verwendung der bilayer-vesikel.
JPS56118013A (en) * 1980-02-25 1981-09-16 Teijin Ltd Calcitonin pharmaceutical and its preparation
JPS56138110A (en) * 1980-03-28 1981-10-28 Teijin Ltd Suppository containing citric acid or salt thereof
JPS56138115A (en) * 1980-03-31 1981-10-28 Teijin Ltd Suppository containing acidic amino acid or derivative thereof
DE3171774D1 (en) * 1980-03-31 1985-09-19 Teijin Ltd Pharmaceutical composition for intrarectal administration, and suppository prepared therefrom
IL64397A0 (en) * 1981-01-07 1982-02-28 Weder Hans G Process for the preparation of liposomal medicaments
IL70489A0 (en) * 1982-12-29 1984-03-30 Armour Pharma Pharmaceutical compositions containing calcitonin
US4801577A (en) * 1987-02-05 1989-01-31 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide analogs of LHRH useful as LHRH antagonists
IT1222734B (it) * 1987-09-25 1990-09-12 Scalvo S P A Formulaziopne farmaceutiche e forme di dosaggio per la somminaistarzione rettale di calcitonina

Also Published As

Publication number Publication date
IL87747A0 (en) 1989-02-28
PT88491B (pt) 1992-11-30
GB8821429D0 (en) 1988-10-12
NL8802274A (nl) 1989-04-03
DK509888D0 (da) 1988-09-13
FI87889C (fi) 1993-03-10
SE8803222L (sv) 1989-03-16
MY103611A (en) 1993-08-28
PH24766A (en) 1990-10-01
LU87334A1 (fr) 1989-07-07
NO884053D0 (no) 1988-09-13
GB2209670B (en) 1991-05-08
BE1001937A3 (fr) 1990-04-17
ATA224788A (de) 1993-01-15
HU203204B (en) 1991-06-28
NO884053L (no) 1989-03-16
NO175518B (no) 1994-07-18
HK19394A (en) 1994-03-18
AT396424B (de) 1993-09-27
AU614769B2 (en) 1991-09-12
GB2209670A (en) 1989-05-24
FI87889B (fi) 1992-11-30
FI884191A (fi) 1989-03-16
KR970003052B1 (ko) 1997-03-14
CH677320A5 (es) 1991-05-15
DK509888A (da) 1989-03-16
FR2620331A1 (fr) 1989-03-17
NO175518C (no) 1994-10-26
SE8803222D0 (sv) 1988-09-13
PT88491A (pt) 1988-10-01
US5149537A (en) 1992-09-22
AU2217588A (en) 1989-04-20
CA1330417C (en) 1994-06-28
HUT47864A (en) 1989-04-28
FI884191A0 (fi) 1988-09-13
FR2620331B1 (fr) 1991-11-08
NZ226162A (en) 1991-03-26
JPH01228919A (ja) 1989-09-12
CY1763A (en) 1994-07-15
KR890004680A (ko) 1989-05-09
ES2012119A6 (es) 1990-03-01
DE3830245A1 (de) 1989-03-30

Similar Documents

Publication Publication Date Title
IL87747A (en) Suppositories containing a calcitonin and taurocholic acid or a pharmaceutically acceptable salt thereof as resorption enhancer
GB8713662D0 (en) Hyaluronic acid derivatives
GB2207672B (en) Sulphonamidothienylcarboxyic acid compounds
GB2203149B (en) New ribofuranuronic acid derivatives
GB2213121B (en) Orientation of containers
AU102037S (en) A strip of containers
GB2203430B (en) Pyrimidinecarboxylic acid derivatives
ZA898780B (en) Pyrrolidone-2-carboxylic acid derivatives having a psychotropic action
ZA895238B (en) Production of chloric acid
IL80181A0 (en) Preparation of an azetidine-3-carboxylic acid or a salt thereof
GB8624875D0 (en) 2 6-naphthalenedi-carboxylic acid
NZ230298A (en) Renin-inhibitory peptide derivatives containing a suleptanic acid moiety
GB8813889D0 (en) Solutions of permonosulphuric acid
GB8528960D0 (en) Persilylated carboxylic acid amides
GB8702901D0 (en) Substituted 1 2 3 4-tetrahydropyrimidine
NZ225221A (en) Preparation of a piperidinylcyclopentylheptenoic acid or derivative and intermediate therefor
SG12694G (en) Suppository comprising a calcitonin and taurocholic acid or a salt thereof.
JPS6413065A (en) Peptide derivative of beta-chloro-l-(z)- dehydroglutamic acid
GB2181170B (en) A nail bracket
GB8507859D0 (en) Purity of salt
GB8717997D0 (en) Derivatives of benzoyloxyacetic acid
IE870807L (en) Malonic acid derivatives
IE870632L (en) Pyrimidine carboxylic acid derivatives
GB8909882D0 (en) Purification of 2-keto-1-gulonic acid
GR871913B (en) Manufacture of a fastening mechanism for a mop

Legal Events

Date Code Title Description
RH Patent void